Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 83
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06701396 | Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant | ||
| NCT06494397 | Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions | ||
| NCT05361707 | Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances | ||
| NCT04327661 | Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT04856917 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | ||
| NCT01429116 | Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception | ||
| NCT04127058 | Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia | ||
| NCT02970968 | Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis | ||
| NCT04712734 | A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia | ||
| NCT04697069 | A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash | ||
| NCT04697056 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis | ||
| NCT04353401 | WGS Analysis of COVID-19 Positive Patients | ||
| NCT07221578 | Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder | ||
| NCT07065773 | Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis | ||
| NCT05344365 | A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis | ||
| NCT04969211 | Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers | ||
| NCT03373201 | Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | ||
| NCT00467441 | VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness | ||
| NCT01637636 | Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. | ||
| NCT06961968 | Randomized Withdrawal Study in Patients With Schizophrenia | ||
| NCT04140695 | Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) | ||
| NCT07090161 | Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension | ||
| NCT02231008 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | ||
| NCT01430754 | Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder | ||
| NCT06323655 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects | ||
| NCT01526746 | Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function | ||
| NCT01271387 | Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment | ||
| NCT04652882 | Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | ||
| NCT07362017 | Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis | ||
| NCT00254202 | Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia | ||
| NCT01578057 | Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol | ||
| NCT01540500 | Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine | ||
| NCT02130999 | Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™) | ||
| NCT06804603 | A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist Use | ||
| NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | ||
| NCT04028492 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | ||
| NCT00490945 | Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers | ||
| NCT04800237 | Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety | ||
| NCT01195558 | Patient Registry of Blind Subjects With Sleep-related Problems | ||
| NCT01919944 | Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P | ||
| NCT03291041 | A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder | ||
| NCT01218789 | Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception | ||
| NCT03633396 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis | ||
| NCT02180451 | Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS) | ||
| NCT02560103 | An Observational Study to Investigate the Effects of Rapid Transmeridian Travel | ||
| NCT01428661 | Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder | ||
| NCT05352893 | Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP | ||
| NCT01477619 | Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects | ||
| NCT04819776 | Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder | ||
| NCT05922995 | The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD) |
